Akebia Therapeutics AKBA
NASDAQ AKBA
$0.58 -0.04 (-6.15%)
As of: Oct 21, 2026 · 3:13 PM EDT

Akebia Therapeutics (AKBA) Current Taxes (2017 - 2018)

Updated

Akebia Therapeutics' Current Taxes came in at $987,000 for Q1 2018, unchanged from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Current Taxes (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn -
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn 1.05 Bn
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn -
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn 1.47 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn -
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn -
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn 653.00 Mn
10 Akebia Therapeutics 156.40 Mn -513.08 Mn 38.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 987,000.00
Dec 31, 2017 987,000.00
API Access

Akebia Therapeutics Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=AKBA&period=max&api_key=YOUR_API_KEY